Matches in Nanopublications for { ?s ?p "[Regular use of long-acting beta(2)-agonists is not associated with significant tolerance to their bronchodilator action, impairment in the response to albuterol, decreased baseline pulmonary function, increased response to methacholine, or increased risk of adverse cardiac events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP587936.RAWjoIvNFmWXSWa2Lvm4Jm83aE96KCAGdPWRnszfb46Ck130_assertion description "[Regular use of long-acting beta(2)-agonists is not associated with significant tolerance to their bronchodilator action, impairment in the response to albuterol, decreased baseline pulmonary function, increased response to methacholine, or increased risk of adverse cardiac events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP587936.RAWjoIvNFmWXSWa2Lvm4Jm83aE96KCAGdPWRnszfb46Ck130_provenance.
- NP842140.RAWRzSxjznPDOGm9iITENJbbJupcuI87xzdcTHSDKfmJE130_assertion description "[Regular use of long-acting beta(2)-agonists is not associated with significant tolerance to their bronchodilator action, impairment in the response to albuterol, decreased baseline pulmonary function, increased response to methacholine, or increased risk of adverse cardiac events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP842140.RAWRzSxjznPDOGm9iITENJbbJupcuI87xzdcTHSDKfmJE130_provenance.
- NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_assertion description "[Regular use of long-acting beta(2)-agonists is not associated with significant tolerance to their bronchodilator action, impairment in the response to albuterol, decreased baseline pulmonary function, increased response to methacholine, or increased risk of adverse cardiac events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1002154.RAVkmsQWr0oKXNYiLK3p2JTWPHDX5Z0IjzKqtt_stYYSE130_provenance.
- assertion description "[Regular use of long-acting beta(2)-agonists is not associated with significant tolerance to their bronchodilator action, impairment in the response to albuterol, decreased baseline pulmonary function, increased response to methacholine, or increased risk of adverse cardiac events.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.